Amelioration of Endotoxin-Induced Inflammatory Toxic Response by a Metal Chelator in Rat Eyes

Metal ions play a key role in exacerbating toxicity associated with oxidative stress and inflammation. This study examines the effects of a formulation containing the metal chelator ethylenediaminetetraacetic acid (EDTA) and permeability enhancer methyl sulfonyl methane (MSM) on the early course of...

Full description

Saved in:
Bibliographic Details
Published inInvestigative ophthalmology & visual science Vol. 59; no. 1; pp. 31 - 38
Main Authors Shoeb, Mohammad, Zhang, Min, Xiao, Tianlin, Syed, Misha F, Ansari, Naseem H
Format Journal Article
LanguageEnglish
Published United States The Association for Research in Vision and Ophthalmology 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Metal ions play a key role in exacerbating toxicity associated with oxidative stress and inflammation. This study examines the effects of a formulation containing the metal chelator ethylenediaminetetraacetic acid (EDTA) and permeability enhancer methyl sulfonyl methane (MSM) on the early course of inflammation in endotoxin-induced uveitis (EIU). The proprietary MSM/EDTA formulation of Livionex, Inc., which was used for this study, is covered by several patents and pending patent applications. EIU was induced by using subcutaneous injection of lipopolysaccharide (LPS) into the thighs of Lewis rats. Treatment consisted of topical application to the eyes of either PBS or eye drops designated as ME that contain EDTA and MSM. Clinical signs of uveitis were monitored at 6 and 24 hours postinjection. Oxidative and inflammatory markers were evaluated by ELISA or immunohistochemistry. Rats treated with ME showed fewer clinical signs of uveitis including reduced miosis, fibrinous exudates, and dilated blood vessels. The aqueous humor of treated rats contained fewer leukocytes, lower protein levels, and less PGE2. Formation of protein adducts with the lipid peroxidation end-product, 4-hydroxynonenal, expression of NF-κB, TNF-α, and MMP-9 were all reduced in rats treated with ME. Our results indicate that ME eye drops downregulate the ocular inflammatory response in LPS treated rats, suggesting that induction of EIU involves metal ions and chelation therapy with ME is a potential treatment for uveitis.
AbstractList PurposeMetal ions play a key role in exacerbating toxicity associated with oxidative stress and inflammation. This study examines the effects of a formulation containing the metal chelator ethylenediaminetetraacetic acid (EDTA) and permeability enhancer methyl sulfonyl methane (MSM) on the early course of inflammation in endotoxin-induced uveitis (EIU). The proprietary MSM/EDTA formulation of Livionex, Inc., which was used for this study, is covered by several patents and pending patent applications.MethodsEIU was induced by using subcutaneous injection of lipopolysaccharide (LPS) into the thighs of Lewis rats. Treatment consisted of topical application to the eyes of either PBS or eye drops designated as ME that contain EDTA and MSM. Clinical signs of uveitis were monitored at 6 and 24 hours postinjection. Oxidative and inflammatory markers were evaluated by ELISA or immunohistochemistry.ResultsRats treated with ME showed fewer clinical signs of uveitis including reduced miosis, fibrinous exudates, and dilated blood vessels. The aqueous humor of treated rats contained fewer leukocytes, lower protein levels, and less PGE2. Formation of protein adducts with the lipid peroxidation end-product, 4-hydroxynonenal, expression of NF-κB, TNF-α, and MMP-9 were all reduced in rats treated with ME.ConclusionsOur results indicate that ME eye drops downregulate the ocular inflammatory response in LPS treated rats, suggesting that induction of EIU involves metal ions and chelation therapy with ME is a potential treatment for uveitis.
Metal ions play a key role in exacerbating toxicity associated with oxidative stress and inflammation. This study examines the effects of a formulation containing the metal chelator ethylenediaminetetraacetic acid (EDTA) and permeability enhancer methyl sulfonyl methane (MSM) on the early course of inflammation in endotoxin-induced uveitis (EIU). The proprietary MSM/EDTA formulation of Livionex, Inc., which was used for this study, is covered by several patents and pending patent applications. EIU was induced by using subcutaneous injection of lipopolysaccharide (LPS) into the thighs of Lewis rats. Treatment consisted of topical application to the eyes of either PBS or eye drops designated as ME that contain EDTA and MSM. Clinical signs of uveitis were monitored at 6 and 24 hours postinjection. Oxidative and inflammatory markers were evaluated by ELISA or immunohistochemistry. Rats treated with ME showed fewer clinical signs of uveitis including reduced miosis, fibrinous exudates, and dilated blood vessels. The aqueous humor of treated rats contained fewer leukocytes, lower protein levels, and less PGE2. Formation of protein adducts with the lipid peroxidation end-product, 4-hydroxynonenal, expression of NF-κB, TNF-α, and MMP-9 were all reduced in rats treated with ME. Our results indicate that ME eye drops downregulate the ocular inflammatory response in LPS treated rats, suggesting that induction of EIU involves metal ions and chelation therapy with ME is a potential treatment for uveitis.
Author Ansari, Naseem H
Syed, Misha F
Shoeb, Mohammad
Xiao, Tianlin
Zhang, Min
Author_xml – sequence: 1
  givenname: Mohammad
  surname: Shoeb
  fullname: Shoeb, Mohammad
  organization: Departments of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States
– sequence: 2
  givenname: Min
  surname: Zhang
  fullname: Zhang, Min
  organization: Departments of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States
– sequence: 3
  givenname: Tianlin
  surname: Xiao
  fullname: Xiao, Tianlin
  organization: Departments of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States
– sequence: 4
  givenname: Misha F
  surname: Syed
  fullname: Syed, Misha F
  organization: Ophthalmology and Visual Science, University of Texas Medical Branch, Galveston, Texas, United States
– sequence: 5
  givenname: Naseem H
  surname: Ansari
  fullname: Ansari, Naseem H
  organization: Ophthalmology and Visual Science, University of Texas Medical Branch, Galveston, Texas, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29302691$$D View this record in MEDLINE/PubMed
BookMark eNpVkUFLAzEQhYNUbKsevUqOXrYm2SbZvQilVC1UhFKPErLZWRvZTepmW-y_d2trqXOZgffxZobXRx3nHSB0Q8mAUiHvrd-EAZURY1SyM9SjnLOIyyTunMxd1A_hkxBGKSMXqMvSmDCR0h56H1VQWl_rxnqHfYEnLveN_7Yumrp8bSDHU1eUuqp04-stXrSSwXMIK-8C4GyLNX6BRpd4vIRyx2Dr8Fw3eLKFcIXOC10GuD70S_T2OFmMn6PZ69N0PJpFJk5kE4mcmyQXIEjOi2ECnEmaAJAso1rrlHApuJSxGba_SC0ZKyRpqzApTQUQHV-ih73vap1VkBtwTa1Ltaptpeut8tqq_4qzS_XhN4pLPqSpbA3uDga1_1pDaFRlg4Gy1A78OiiaJimPJRGiRaM9amofQg3FcQ0laheJ2kWiqFS_kbT87eltR_ovg_gHyQiKng
CitedBy_id crossref_primary_10_3390_ijms24108653
crossref_primary_10_3390_antiox10071092
crossref_primary_10_1093_burnst_tkaa024
crossref_primary_10_3389_fimmu_2019_00389
crossref_primary_10_3389_fphar_2020_585446
ContentType Journal Article
Copyright Copyright 2018 The Authors 2018
Copyright_xml – notice: Copyright 2018 The Authors 2018
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1167/iovs.17-22172
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Topical Metal Chelation Ameliorates Ocular Inflammation
EISSN 1552-5783
EndPage 38
ExternalDocumentID 10_1167_iovs_17_22172
29302691
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: P30 ES006676
– fundername: NEI NIH HHS
  grantid: R01 EY013014
GroupedDBID ---
18M
2WC
34G
39C
5GY
5RE
ACGFO
ACNCT
ADBBV
AENEX
AFOSN
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
GROUPED_DOAJ
GX1
N9A
NPM
OK1
P2P
RHF
RPM
SJN
TR2
TRV
W8F
WH7
WOQ
WOW
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c387t-6d5c8d6e60d5f48e52718ee0bb1aaa905765773c45787a722f70000fc9196e0a3
IEDL.DBID RPM
ISSN 1552-5783
0146-0404
IngestDate Tue Sep 17 21:16:01 EDT 2024
Thu Jul 25 10:36:08 EDT 2024
Fri Aug 23 02:19:07 EDT 2024
Sat Sep 28 08:49:29 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c387t-6d5c8d6e60d5f48e52718ee0bb1aaa905765773c45787a722f70000fc9196e0a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754197/
PMID 29302691
PQID 1989537066
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5754197
proquest_miscellaneous_1989537066
crossref_primary_10_1167_iovs_17_22172
pubmed_primary_29302691
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Investigative ophthalmology & visual science
PublicationTitleAlternate Invest Ophthalmol Vis Sci
PublicationYear 2018
Publisher The Association for Research in Vision and Ophthalmology
Publisher_xml – name: The Association for Research in Vision and Ophthalmology
References 16361678 - Br J Ophthalmol. 2006 Jan;90(1):103-8
19136698 - Invest Ophthalmol Vis Sci. 2009 May;50(5):2276-82
16055157 - Mutat Res. 2005 Nov 11;579(1-2):22-36
21551413 - Invest Ophthalmol Vis Sci. 2011 Jul 11;52(8):5144-52
16839504 - Curr Rheumatol Rep. 2006 Aug;8(4):260-6
15857275 - J Ocul Pharmacol Ther. 2005 Apr;21(2):95-106
8407215 - Invest Ophthalmol Vis Sci. 1993 Oct;34(11):3084-9
11239407 - Cell. 2001 Feb 23;104(4):487-501
1937131 - Free Radic Biol Med. 1991;11(1):81-128
3141538 - J Ocul Pharmacol. 1987 Fall;3(3):199-210
16052571 - Arthritis Rheum. 2005 Aug;52(8):2478-84
1782799 - Curr Eye Res. 1991 Nov;10(11):1009-14
12714660 - Invest Ophthalmol Vis Sci. 2003 May;44(5):2184-91
11864886 - Br J Ophthalmol. 2002 Mar;86(3):290-5
12766073 - Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2683-8
3257741 - Graefes Arch Clin Exp Ophthalmol. 1988;226(1):27-30
3019289 - Arch Ophthalmol. 1986 Sep;104(9):1369-71
19538004 - Drug Deliv. 2009 Jul;16(5):243-8
15218543 - Acta Biochim Pol. 2004;51(2):471-80
8360023 - Invest Ophthalmol Vis Sci. 1993 Sep;34(10):2911-7
21271438 - J Toxicol Environ Health A. 2011;74(6):380-91
23892029 - Int Immunopharmacol. 2013 Oct;17 (2):439-46
8595963 - Invest Ophthalmol Vis Sci. 1996 Mar;37(4):630-6
15808518 - Toxicol Appl Pharmacol. 2005 Apr 15;204(2):122-34
11522450 - Free Radic Biol Med. 2001 Sep 1;31(5):651-8
8897058 - Graefes Arch Clin Exp Ophthalmol. 1996 Oct;234(10):643-7
16464088 - J Am Chem Soc. 2006 Feb 15;128(6):1879-85
16723122 - Biochem Pharmacol. 2006 Nov 30;72(11):1493-505
24509160 - Free Radic Biol Med. 2014 Apr;69:289-99
12775361 - Mediators Inflamm. 2003 Apr;12(2):107-16
7867220 - Clin Biochem. 1994 Oct;27(5):413-8
15157161 - Biochem Soc Trans. 2004 Jun;32(Pt3):465-7
6263951 - J Clin Invest. 1981 Jun;67(6):1724-8
8641467 - FEBS Lett. 1996 Apr 29;385(1-2):58-62
11586057 - Ophthalmic Res. 2001 Sep-Oct;33(5):251-5
1691157 - Int Ophthalmol. 1990 Jan;14(1):31-6
1407958 - Ophthalmic Res. 1992;24(3):162-8
7962479 - J Neuroimmunol. 1994 Nov;55(1):1-9
11841926 - Free Radic Biol Med. 2002 Feb 15;32(4):360-9
19774675 - J Neurosci Res. 2010 Feb 15;88(3):686-94
21354119 - Chem Biol Interact. 2011 May 30;191(1-3):330-8
12867408 - Ophthalmology. 2003 Jul;110(7):1449-53
11193167 - Ann N Y Acad Sci. 2000;920:292-304
8962842 - Br J Ophthalmol. 1996 Sep;80(9):844-8
10927169 - Free Radic Biol Med. 2000 May 15;28(10):1456-62
9893027 - Immunol Cell Biol. 1998 Dec;76(6):497-512
10517532 - Free Radic Res. 1999 Oct;31(4):261-72
8125720 - Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1100-6
19279313 - Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3512-9
12167248 - DNA Cell Biol. 2002 May-Jun;21(5-6):453-9
7402339 - Nature. 1980 Aug 7;286(5773):611-3
15579100 - Curr Top Med Chem. 2004;4(15):1623-35
References_xml
SSID ssj0021120
Score 2.3301167
Snippet Metal ions play a key role in exacerbating toxicity associated with oxidative stress and inflammation. This study examines the effects of a formulation...
PurposeMetal ions play a key role in exacerbating toxicity associated with oxidative stress and inflammation. This study examines the effects of a formulation...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 31
SubjectTerms Animals
Aqueous Humor - drug effects
Aqueous Humor - metabolism
Biochemistry and Molecular Biology
Calcium Chelating Agents - therapeutic use
Cytokines - biosynthesis
Cytokines - drug effects
Disease Models, Animal
Edetic Acid - therapeutic use
Male
Oxidative Stress
Rats
Rats, Inbred Lew
Uveitis - diagnosis
Uveitis - drug therapy
Uveitis - metabolism
Title Amelioration of Endotoxin-Induced Inflammatory Toxic Response by a Metal Chelator in Rat Eyes
URI https://www.ncbi.nlm.nih.gov/pubmed/29302691
https://search.proquest.com/docview/1989537066
https://pubmed.ncbi.nlm.nih.gov/PMC5754197
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SHEovpe9u2ywqlN6064essY9h2ZC0bCkhgVyKkewRMWTlkGxC8u878iNk21uvlizM6JPmG8-nEcBXrSjSjmJpFSqpaofSYGYlP04YYGTiXm3xUx-dqe_n2fkOZONZmE60X9lm5i_XM99cdNrKq3U1H3Vi81-rBVMMFRc434VdTNMxRB-irHioxchbgGSEqrGwpsZ5097dzHhXTsKtTKEMcJFyCFLE2z7pH6L5t17yiQM6fAkvBuYoDvovfAU75F_Ds9WQG38Dvw_WdNkMMypaJ5aeI872vvEy3M9RUS2OvWMArLvEujjlpkqc9BpZEvZBGLEi5uJicREUcu21aLw4MRuxfKCbt3B2uDxdHMnh8gRZpTlupK6zKq816ajOnMopS9gLEUXWxsaYgmmazhDTSoUlazBJHAbf5aqC1yRFJn0He7719AEEasprMqmLTR3yutZi5LS2igeipHAT-Daar7zqa2SUXWyhsQwmL2MsO5NP4Mto3JJRHFITxlN7yz2KvMhSZP4zgfe9sR-HGmdpArg1DY8dQoXs7RYGTlcpewDKx_9-8xM8Z4aU9_9cPsPe5vqW9pmFbOyU-ffxj2kXw087BP4B6yrfLQ
link.rule.ids 230,315,733,786,790,870,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgGXlneXFjAS4pZsHo6dHKvVVlvoVqjaol5QZCdjNaLrVG0WUX59x3lUbDnBNeNYib6x55vMlzHAR8ExEAZDT3PJPV4a6SmZaI8uR-RgqMJObXEsZqf881lytgHJ8C9MK9ovdOXbi6Vvq_NWW3m5LMaDTmz8dT4hisHDTI4fwENar5EckvQ-zwr7boy0CXjko3xorSnkuKp_Xvu0L0fuXCbXCDiLKQnJwvWo9BfVvK-Y_CMEHWzDt-HhO-XJD3_VaL_4fa-v4z-_3VPY6kkp2-_Mz2AD7XN4NO_L7i_g-_4SL6reWVht2NRSMlv_qqznjv4osGSH1pBvLduaPVuQqWAnnfwWmb5his2RaD6bnDvxXX3FKstOVMOmN3j9Ek4PpovJzOvPZfCKOJWNJ8qkSEuBIigTw1NMIgpwiIHWoVIqIwYoEinjgrvdQMkoMtKFRVNktNwxUPEr2LS1xR1gUmBaoopNqEpXMtZaBkYIzWkijDIzgk8DLvll134jb9MWIXOHZR7KvMVyBB8G1HJaIK7qoSzWKxqRpVkSS6JWI3jdoXg31QD_COQavncDXPPtdQuh1jbh7lF68993vofHs8X8KD86PP6yC0-IiKXdp5092GyuVviWyE6j37WufQtILf89
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBZtCqEvvZtuTxVK3-RTlqzHsN0labshhARCoRjJHhHTrLwk3tL013fkI2TTt7xaB4hvpPnG8zFDyCfBIRIWYma45IxXVjItM8Pwc4IGBjru1RYHYu-Efz3NTm-0-upE-6WpA3e-DFx91mkrV8syHHVi4eFiihSDx0qGq8qG98kDvLOJGgP1IdaKh4qM-BAwtFM-ltcUMqyb35cBvs2J783kiwGrFAMRFW96pv_o5m3V5A03NH9MfowH6NUnv4J1a4Ly763ajnc64RPyaCCndLef8pTcA_eMbC-G9Ptz8nN3Cef1YDS0sXTmMKht_tSO-RYgJVR031m0sWWXu6fHOFTSo16GC9RcUU0XgHSfTs-8CK-5oLWjR7qlsyu4fEFO5rPj6R4b-jOwMs1ly0SVlXklQERVZnkOWYKODiAyJtZaK2SCIpMyLbl_FbRMEiu9e7SlwmsPkU5fki3XOHhFqBSQV6BTG-vKp46NkZEVwnDcCBJlJ-TziE2x6stwFF34ImTh8SxiWXR4TsjHEbkCL4rPfmgHzRpnqFxlqUSKNSE7PZLXW40mMCFyA-PrCb4I9-YIItcV4x6Qen3nlR_I9uGXefF9_-DbG_IQ-Vje_-F5S7baizW8Q87Tmveddf8DSj8BzA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Amelioration+of+Endotoxin-Induced+Inflammatory+Toxic+Response+by+a+Metal+Chelator+in+Rat+Eyes&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Shoeb%2C+Mohammad&rft.au=Zhang%2C+Min&rft.au=Xiao%2C+Tianlin&rft.au=Syed%2C+Misha+F&rft.date=2018-01-01&rft.eissn=1552-5783&rft.volume=59&rft.issue=1&rft.spage=31&rft.epage=38&rft_id=info:doi/10.1167%2Fiovs.17-22172&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon